FDA Brief

Warning letters Food

FDA warning letter to

Royal Diamond Imports, Inc.

High riskIssued Jun 25, 2025Posted Jul 15, 2025Human Foods Program

FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.

What happened

FDA reviewed the company's website, www.roxytabs.com, and product labeling rather than doing an inspection. The review found the tablets promoted for relaxation, mood, pain relief, anxiety and sleep, including customer testimonials about pain and chronic disease, which FDA says makes them drugs. For the Roxy Instamix drink mix, FDA said the added kratom extract is not an approved food additive and is not generally recognized as safe, so the drink mix is adulterated (contains an illegal ingredient).

What FDA found

  1. The passion fruit drink mix contains kratom extract, which is not an approved food additive and is not generally recognized as safe, so the food is adulterated.

    Sections 402(a)(2)(C)(i) and 409(a) of the Act (21 U.S.C. 342(a)(2)(C)(i), 348(a))
  2. Website claims and customer testimonials show the tablets are meant to treat disease or change how the body works, which makes them drugs.

    Section 201(g)(1) of the Act (21 U.S.C. 321(g)(1))
  3. The tablets are 'new drugs' (not generally recognized as safe and effective, and without FDA approval) and are sold without an approved application.

    Sections 505(a) and 301(d) of the Act (21 U.S.C. 355(a) and 331(d))
  4. Shipping the adulterated drink mix across state lines is prohibited.

    Section 301(a) of the Act (21 U.S.C. 331(a))
  5. FDA cites no basis to treat kratom extract as generally recognized as safe, based on science or on common use in food before 1958.

    21 CFR 170.30(a)-(c)

What FDA wants

FDA asks the company to write to its Compliance Officer within 15 working days describing the specific steps taken to fix the violations and prevent them from recurring, with supporting documents. If the work cannot be finished in that time, the company must explain why and give a date for completion.

Who should pay attention

  • retailers and online sellers of kratom and 7-OH products
  • brands adding kratom extract to foods or drink mixes
  • distributors and convenience-store buyers of Roxy-branded tablets

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk